For FDA-approved GLP-1 medications, contraindications include a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, and a history of severe allergic reaction to the drug
PEAK manages this process, prescribing Contrave, documenting your response, and building the case for GLP-1 approval
Contrave combines naltrexone and bupropion to affect appetite and reward pathways, achieving less pronounced weight loss
Sustainable pace where you can still talk but its slightly challenging
Mounjaro, and other weight loss injections, like Ozempic and Wegovy, are similar
Serious Potential Side Effects Pancreatitis, gallbladder issues, kidney problems, and increased heart rate, thyroid cancer, anaphylaxis (or serious allergic reactions) Bupropion enhances dopamine and norepinephrine activity, reducing appetite and cravings